Compare INGR & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGR | ACHC |
|---|---|---|
| Founded | 1906 | 2005 |
| Country | United States | United States |
| Employees | N/A | 25500 |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 1.3B |
| IPO Year | 1997 | N/A |
| Metric | INGR | ACHC |
|---|---|---|
| Price | $111.57 | $14.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $134.57 | $24.38 |
| AVG Volume (30 Days) | 702.7K | ★ 3.5M |
| Earning Date | 02-03-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 10.01 | 1.18 |
| Revenue | ★ $7,262,000,000.00 | $3,265,548,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | $1.23 | $4.38 |
| P/E Ratio | ★ $11.21 | $12.24 |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $102.31 | $12.63 |
| 52 Week High | $144.66 | $47.08 |
| Indicator | INGR | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 38.08 |
| Support Level | $105.83 | $13.99 |
| Resistance Level | $113.90 | $14.70 |
| Average True Range (ATR) | 1.70 | 0.87 |
| MACD | 0.89 | 0.18 |
| Stochastic Oscillator | 71.13 | 41.12 |
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.